Evidence map›Paper›PMID 35007996›Full record

ArticleESMO open2022

The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey series.

K H J Lim, K Murali, E Thorne, K Punie, K Kamposioras, C Oing, M O'Connor, E Élez, T Amaral, P Garrido and 7 more

Abstract read
In one paragraph

Article in ESMO open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Faculty of Radiation Oncology 2022 New Zealand Workforce Census.Journal of medical imaging and radiation oncology · 2026
    Article
  2. Article
  3. Impact of COVID-19 on early identification of protein-energy malnutrition in the cancer care setting: a repeated cross-sectional survey of cancer care professionals.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  4. Faculty of Radiation Oncology 2022 Workforce Census.Journal of medical imaging and radiation oncology · 2025
    Review
  5. Mistletoe in Cancer Cell Biology: Recent Advances.Current issues in molecular biology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Transforming post pandemic cancer services.British journal of cancer · 2024
    Review
  15. Article
  16. Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  17. Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

K H J LimDepartment of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Immunology and Inflammation, Imperial College London, London, UK; Immunobiology Laboratory, The Francis Crick Institute, London, UK.
K MuraliVictorian Clinical Genetics Services & Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Australia.
E ThorneDivision of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.
K PunieDepartment of General Medical Oncology and Multidisciplinary Breast Center, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium. Electronic address: https://twitter.com/kevinpunie.
K KamposiorasDepartment of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
C OingDepartment of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, Mildred Scheel Cancer Career Centre HaTriCs4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: https://twitter.com/OingC1.
M O'ConnorUniversity Hospital Waterford, Waterford, Ireland.
E ÉlezVall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: https://twitter.com/elena_elez.
T AmaralDepartment of Dermatology, University Hospital Tübingen, Tübingen, Germany. Electronic address: https://twitter.com/TeresaSAmaral.
P GarridoMedical Oncology, Hospital Ramón y Cajal, IRYCIS, Alcalá University, Madrid, Spain. Electronic address: https://twitter.com/Piuchagarrido.
M LambertiniDepartment of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy; Department of Internal Medicine and Medical Sciences (DiMI), School of Medicine, University of Genoa, Genoa, Italy. Electronic address: https://twitter.com/matteolambe.
B DevnaniDepartment of Radiotherapy and Oncology, All India Institute of Medical Sciences, Jodhpur, India. Electronic address: https://twitter.com/devnani_bharti.
C B WestphalenDepartment of Internal Medicine III, University Hospital, LMU Munich and Comprehensive Cancer Center, Munich, Germany. Electronic address: https://twitter.com/BenWestphalen.
G MorganDepartment of Medical and Radiation Oncology, Skåne University Hospital, Lund, Sweden. Electronic address: https://twitter.com/weoncologists.
J B A G HaanenDivision of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: https://twitter.com/HaanenJohn.
C HardyDivision of Health Research, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.
S BanerjeeGynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK; The Institute of Cancer Research, London, UK. Electronic address: susana.banerjee@rmh.nhs.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 has had a significant impact on the well-being and job performance of oncology professionals globally. The European Society for Medical Oncology (ESMO) Resilience Task Force collaboration set out to investigate and monitor well-being since COVID-19 in relation to work, lifestyle and support factors in oncology professionals 1 year on since the start of the pandemic.

methodsAn online, anonymous survey was conducted in February/March 2021 (Survey III). Key outcome variables included risk of poor well-being or distress (expanded Well-Being Index), feeling burnout (single item from expanded Well-Being Index), and job performance since COVID-19. Longitudinal analysis of responses to the series of three surveys since COVID-19 was carried out, and responses to job demands and resources questions were interrogated. SPSS V.26.0/V.27.0 and GraphPad Prism V9.0 were used for statistical analyses.

resultsResponses from 1269 participants from 104 countries were analysed in Survey III: 55% (n = 699/1269) female, 54% (n = 686/1269) >40 years, and 69% (n = 852/1230) of white ethnicity. There continues to be an increased risk of poor well-being or distress (n = 464/1169, 40%) and feeling burnout (n = 660/1169, 57%) compared with Survey I (25% and 38% respectively, P < 0.0001), despite improved job performance. Compared with the initial period of the pandemic, more participants report feeling overwhelmed with workload (45% versus 29%, P < 0.0001). There remain concerns about the negative impact of the pandemic on career development/training (43%), job security (37%). and international fellowship opportunities (76%). Alarmingly, 25% (n = 266/1086) are considering changing their future career with 38% (n = 100/266) contemplating leaving the profession.

conclusionOncology professionals continue to face increased job demands. There is now significant concern regarding potential attrition in the oncology workforce. National and international stakeholders must act immediately and work closely with oncology professionals to draw up future-proof recovery plans.

Indexed as

Burnout, ProfessionalCOVID-19Health PersonnelMedical OncologyEuropeFemaleHumansPandemicsSocieties, MedicalburnoutCOVID-19job performanceoncology professionalsresiliencewell-being

Identifiers

PMID35007996
PMCPMC8677468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.